Total hip and knee replacement surgery using metal alloy devices is common. Type IV allergic reactions to these implants occur, though infrequently. While uncommon, peri-implant metal allergic reactions may cause significant morbidity for the affected individualincluding aseptic loosening, pseudotumor formation and frank device failure. It is challenging to predict who will have these reactions, even in those with established pre-implant metal allergy. At this time, the scientific literature clearly supports few conclusions. Despite this, we believe several conclusions can be made: routine pre-implant testing in asymptomatic individuals is not indicated; listen to patient's concerns about metal allergy if the concern arises; patch testing is probably the best pre-and post-implant screening test; post-implantation testing is controversial and even positive LTT or patch test does not definitively diagnose morbidity from a metal allergy; and complete recovery following revision placement of an immunologically inert device is diagnostic.
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INTRODUCTION
The use of metals in orthopedics is widespread, and there has been increasing concern with regards to the possibility of developing cutaneous and systemic hypersensitivity reactions to constituent metals in implant devices. Although hypersensitivity reactions to metals are not common, they require evaluation and management when they do occur. Regrettably, there is an ostensible lack hypersensitivity reactions to metallic implants in orthopedic surgery and, in particular, highlight the recent debate surrounding appropriate pre-and post-implantation testing.
In the United States, approximately 5.2 million total knee replacements were performed from 2000 to 2010 [1] and these may double by 2020 [2] . For patients over 45 years old, total hip replacements more than doubled, with 310,800 procedures being performed in 2010 [1] . The total incidence of total shoulder arthroplasty has also been steadily increasing, to 27,000 in 2008 [3] . Orthopedic implants are composed of nickel, cobalt, chromium, molybdenum, zirconium and/or titanium alloys, while stainless steel is used in fixed orthopedic devices such as screws/plates [4, 5, 30] . As a cause of complication after joint replacement, metal allergy was first reported in 1966, with slowly increasing awareness and reported incidence [6] [7] [8] [9] [10] . While the association between metal implant failure and allergy is well documented, it remains a phenomenon that is relatively unpredictable, poorly understood and highly debated [11] [12] [13] .
Skin reactions caused by MHR include dermatitis reactions adjacent to and regionally adjacent to the implant site, generalized dermatitis, as well as erythema, generalized urticaria and cutaneous vasculitis. Reactions occur following implantation of static implants as well as dynamic prostheses [14] [15] [16] [17] [18] [19] . Other adverse reactions including device failure, chronic inflammation, pain, loosening of joint prostheses or re-stenosis of cardiac stents can also occur [20] . In some cases, metallosis (metallic staining of the surrounding tissue), excessive periprosthetic fibrosis and muscular necrosis have also been reported [21] [22] [23] .
With an aging population, clarifying the association between metal hypersensitivity reactions and implant failures bears enormous repercussions for health care costs, and avoids unnecessary morbidity in patients [24] . The lack of clear evidence-based clinical guidance in this area creates a potential breeding ground for unwarranted lawsuits, particularly when patients with self-reported metal allergies pre-implantation allege inadequate pre-operative allergy assessment [25] .
Consequently, the possibility of being entangled in needless litigation provides a strong driving force for seeking clarification and consensus in the field. It is worth noting that the following discussion is based on previously conducted studies, and does not involve any new studies of human or animal subjects performed by any of the authors. [39] . A lymphocyte stimulation test before implantation of a chromium-containing device in those positive for chromium increased the risk of post-implant eczema [39] .
THE ASSOCIATION BETWEEN ORTHOPEDIC IMPLANTS AND METAL HYPERSENSITIVITY
Having said that, metal hypersensitivity reactions following TKA are rare-the exact prevalence of MHR is unknown but estimates ranges from 0 to 5% of implanted devices [20] . [41] . Rates of post-operative pain were similar in those with metal allergy determined by patch testing, compared to control patients. In a separate study, patients receiving a metal TKA showed no increase in joint loosening in those with metal allergy prior to implant as determined by patch testing [42] . Another author concluded that there was no evidence of implant failure due to metal allergy [43] . However, patient-reported allergy was associated with decreased functional outcomes after TKA and poorer scoring of mental health after THA [44] .
Although there are multiple studies for total hip and knee replacements, unfortunately there is no definitive research that reports a link between metal allergy and morbidity following shoulder arthroplasty [4] . There is thus extensive literature on both sides that asserts or renounces a correlation between metal hypersensitivity reaction and metallic implant failure, which only serves to add to the existing confusion. What is clear, however, is that even if a correlation is purported to exist, none of the authors are able to conclusively report the direction of causation.
It remains unknown whether implants fail or function poorly due to a pre-existing metal hypersensitivity, or that secondary sensitization happened due to excessive metal release from failing implants [24] .
THE DEBATE SURROUNDING APPROPRIATE TESTING
Given that there is no clear conclusion on the link between metal allergy and implant failure, it logically follows that there is a similar lack of consensus on the approach to the testing and management of patients. Langerhans cells seem to have a greater antigen-presenting ability when compared to macrophages in the blood [30, 72] . Due to this, some believe that the LTT is more useful for prognosis and diagnosis of metal reactions when compared to patch testing [73, 74] .
Despite this, it is unlikely that the LTT will replace the patch test as the gold standard and most commonly clinically used test. Unfortunately, the LTT is not widely available for clinical use, is not standardized, has inter-laboratory variability and is often not covered by insurance (leading to higher patient costs). Also, the LTT may produce false negative results if the test is not transported and processed in a timely manner. Due to rapid T cell decay, even short delays can lead to false negative results [60] .
At this time, the scientific literature and these authors thus favor the skin patch test as the best available test to evaluate potential metal hypersensitivity reactions, both prior to and following implantation. The role of the LTT remains unclear, but seems to be gaining support for use in conjunction with the patch test and potentially coupled with peri-implant histopathology [60, 67, 75, 76] . Protocols for patch testing have been proposed based on implant type and surgical location [60, 77, 78] .
One suggested use for the LTT is for further evaluation of those patients with negative patch testing and a residual strong clinical suspicion for metal allergy. In an evaluation of 56 patients with titanium alloy implants with systemic symptoms and negative skin patch testing, 54/56 had positive LTT. These 54 had complete symptom resolution after implant replacement with a non-titanium device [79] .
Another study combined three in vitro assays, measuring different aspects of lymphocyte activation in the hope of improving diagnosis [80] . At this time, more research is needed to definitively determine the validity and appropriate clinical use of the LTT [81] .
Post-Implantation Testing
Surprisingly, there is unanimous consensus on how patients with asymptomatic, well-functioning devices should be managed:
there is no indication for metal allergy testing.
Management of patients who suffer from residual post-implantation pain is not as well defined. It is difficult to ascertain, using patch testing alone, if a patient truly does suffer from metal hypersensitivity, and idetermining which patient would benefit from implant removal/ revision is also challenging. Granchi et al.
concluded that testing is indicated in failed metal-on-metal temporomandibular joint replacements with unclear diagnosis [82] . The assumption is that there exist numerous more common causes for pain, loosening and/or failure and that these should be explored prior to considering metal hypersensitivity as the cause.
These include component malalignment, complex regional pain syndrome, crepitation, early aseptic loosening, infection, instability, patellofemoral symptoms or patellar clunk syndrome [83] . For patients who experience residual pain after TKA, metal hypersensitivity should only be suspected if the patient had a normal physical exam and radiographs/CT scans or MARS MRI, and normal laboratory work-up [83] . An alternative approach uses clinical findings to identify those with a high suspicion of metal allergy who may benefit from metal allergy evaluation [77] .
Major diagnostic criteria for post-implantation metal hypersensitivity reactions include [78] :
• Eruption overlying the metal implant.
• Positive patch test reaction to a metal used in the implant.
• Complete recovery after removal of the offending implant.
• Chronic dermatitis beginning weeks to months after metallic implantation.
While reactions considered to be less important are:
• Dermatitis is therapy-resistant.
• Morphology consistent with dermatitis (erythema, induration, papules, vesicles).
• Systemic allergic dermatitis reaction.
• Histology consistent with allergic contact dermatitis.
• Positive in vitro test to metals, e.g., the lymphocyte transformation test.
Paradoxically, to arrive at a definitive diagnosis of metal allergy, it is necessary for the patient to undergo complete resolution of symptoms after device replacement with a non-allergenic implant. In a similar vein, • Reactions to metal orthopedic implants do occur, though rarely, even in those with metal allergy.
• Routine pre-implant testing in asymptomatic individuals is not indicated.
• Listen to patient's concerns about metal allergy if the concern arises.
• Patch testing is probably the best pre-and post-implant screening test.
• Post-implantation testing is controversial and even positive LTT or patch test does not definitively diagnose morbidity from a metal allergy. Complete recovery following revision with an immunologically inert device is diagnostic.
• More research is needed to scientifically approach this issue.
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